Patients should put utensils down between bites and focus on the meal without distractions like television or smartphones
As the popularity of GLP-1 receptor agonists are being shown to benefit many chronic diseases over and above their effect on weight, John Deanfield, FRCP, FESC, professor of cardiology at the Institute of Cardiovascular Sciences at University College London, told Medical News Today
The experiments were approved by the Local Ethics Committee
The second and third doses of vaccine should be given 1 month and 6 months, respectively, after the first
The brand names Ozempic and Rybelsus are approved for the management of type 2 diabetes and can be used in individuals with chronic kidney disease
The Canadian authorization comes amidst a broader effort to extend access to semaglutide